相关实验视频

Updated: Jan 15, 2026

The Intra-Aortic Balloon Pump

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

胰岛素类生长因子结合蛋白2 (IGFBP-2) 作为心脏病发作相关心脏性休克的预后参数

Maryna Masyuk¹, Bernhard Wernly², Malte Kelm³

¹Department of Cardiology, Pulmonology and Vascular Medicine, University Hospital and Medical Faculty, Heinrich-Heine University, Duesseldorf, Germany.

International journal of cardiology

|October 9, 2025

概括

患有急性心肌梗塞与心脏性休克 (AMI-CS) 的患者胰岛素样生长因子结合蛋白2 (IGFBP-2) 水平的升高与30天和一年死亡率的增加有关. IGFBP-2在这个患者群体中显示为风险分层的预后生物标志物.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
临床预后临床预后

背景情况:

带有心脏性休克的急性心肌梗塞 (AMI-CS) 是一种具有高死亡率的危急病.
已知胰岛素类生长因子结合蛋白2 (IGFBP-2) 在心血管疾病中受到失调.

研究的目的:

调查IGFBP-2在被诊断为AMI-CS的患者的预后价值.
为了确定IGFBP-2水平是否可以预测AMI-CS患者的死亡率.

主要方法:

对涉及423名患者的CULPRIT-SHOCK试验进行后期分析.
使用酶相关免疫吸收试验 (ELISA) 工具包测量血清IGFBP-2水平.
研究IGFBP-2水平与30天和一年死亡率之间的关联.

主要成果:

与中位数以下患者相比,IGFBP-2水平在中位数或以上的患者的30天 (54%vs. 37%) 和一年死亡率 (60%vs. 42%) 显着更高.
较高的IGFBP-2度独立地与30天和1年死亡率的增加有关,即使经过对已确定的预后因素进行调整.
每 100 ng/ml 的 IGFBP-2 增加与 6% 的死亡风险比率增加有关 (HR 1.06; 95% CI 1.04-1.09).

结论:

在AMI-CS患者中,IGFBP-2水平升高与30天和一年后死亡率增加相关.
IGFBP-2成为高风险AMI-CS患者风险分层的潜在预后生物标志物.
这种生物标志物可能有助于在AMI-CS管理的早期临床决策.

关键词:

剧烈的心肌梗塞急性心肌梗塞生物标志物生物标志物心脏发生的冲击是心脏的冲击.在 IGFBP-2 中.

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...